Christopher Comeau > Ropes & Gray LLP > Boston, United States > Lawyer Profile

Relying on a strong international network, Ropes & Gray LLP is well versed in national and global corporate and M&A matters, most notably transactions involving the life sciences, biotech and tech sectors. Besides acting for leading corporate clients on buy and sell-side mandates, the group is also adept in high-end de-SPAC deals. Singled out for his in-depth knowledge of corporate transactions concerning the consumer, life sciences and medical technology industries, Christopher Comeau leads the M&A practice out of Boston. Emily Oldshue is a key reference for both public and private companies, private equity firms and investment banks; her most recent advice to Pfizer on several strategic acquisitions is particularly noteworthy. Jackie Cohen, who joined the New York office from Weil, Gotshal & Manges LLP in November 2022, excels in transactional matters, shareholder activism, and takeover defense. Suni Sreepada further strengthened the New York M&A offering in April 2022, when she joined from White & Case LLP. All practitioners are based in Boston unless stated otherwise.

The team at Ropes & Gray LLP provides a diverse offering to biotech startups, biopharmaceutical companies, and private equity investors. The practice handles the full gamut of issues concerning IP asset protection, and research funding. Marc Rubenstein and Michael Beauvais jointly lead the Boston based group. Rubenstein frequently represents pharmaceutical, biotech, and medical device corporates in private securities offerings; while Christopher Comeau acts for investors and public companies in minority investment transactions and private mergers within the medical tech industry. Kellie Combs continues to assist biotech companies with regulatory and compliance issues.